N
Nusano utilizes a proprietary ion source and particle acceleration technology to produce over 40 types of radioisotopes efficiently and affordably, addressing the critical shortage in supply for medical, industrial, and clean energy applications. Their radioisotopes enable precise cancer treatments, enhance industrial operations, and facilitate the generation of clean energy from nuclear waste.
Updated 2 months ago
Funding
$217.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
WGFunding rounds are not available yet.
Founders
Product
Features
- Nusano utilizes a proprietary ion source and particle acceleration technology to produce over 40 types of radioisotopes efficiently and affordably, addressing the critical shortage in supply for medical, industrial, and clean energy applications. Their radioisotopes enable precise cancer treatments, enhance industrial operations, and facilitate the generation of clean energy from nuclear waste.